Home > Signaling Pathways>New Products>New1>Acrizanib (LHA-510)
Acrizanib (LHA-510)

This product is for research use only, not for human use. We do not sell to patients.

Acrizanib (LHA-510)
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
2mg$250To Be Confirmed
5mg$450To Be Confirmed
10mg$750To Be Confirmed
25mg$1250To Be Confirmed
50mg$1950To Be Confirmed
100mg$3250To Be Confirmed

Cat #: V10251 CAS #: 1229453-99-9 Purity ≥ 98%

Description: Acrizanib, formerly known as LHA510, is a novel, potent and selective angiogenesis inhibitor and VEGFR‑2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)445.4062
Molecular FormulaC20H18F3N7O2
CAS No.1229453-99-9
SynonymsAcrizanib; LHA510; LHA 510; LHA-510.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM2.2451 mL11.2257 mL22.4514 mL44.9028 mL
5mM0.4490 mL2.2451 mL4.4903 mL8.9806 mL
10mM0.2245 mL1.1226 mL2.2451 mL4.4903 mL
20mM0.1123 mL0.5613 mL1.1226 mL2.2451 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.